Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill A Ohar

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Proceedings of the American Thoracic Society|August 23, 2005
Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary diseaseJames F Donohue, Jill A Ohar
Seminars in Respiratory and Critical Care Medicine|May 25, 2010
Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPDJill A Ohar, James F Donohue
Current Opinion in Pulmonary Medicine|January 2, 2024
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary diseaseChee Hong Loh, Jill A Ohar
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 22, 2017
Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder InhalersSohini Ghosh, Jill A Ohar, M Bradley Drummond
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 25, 2019
The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive ReviewJill A Ohar, James F Donohue, Selwyn Spangenthal
Drugs|February 10, 2012
Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?Matthew C Miles, James F Donohue, Jill A Ohar
Therapeutic Advances in Respiratory Disease|November 14, 2012
Nebulized arformoterol: what is its place in the management of COPD?Matthew C Miles, James F Donohue, Jill A Ohar
Expert Opinion on Drug Safety|January 8, 2015
Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary diseaseChee H Loh, James F Donohue, Jill A Ohar
Expert Opinion on Drug Safety|January 20, 2015
Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelinesJames F Davidson, James F Donohue, Jill A Ohar
International Journal of Chronic Obstructive Pulmonary Disease|March 16, 2026
Development and Validation of an Electronic Health Record Algorithm to Predict the Presence of Chronic Obstructive Pulmonary DiseaseBrian J Wells, Amit K Saha, Jill A Ohar
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Proceedings of the American Thoracic Society|August 23, 2005
Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary diseaseJames F Donohue, Jill A Ohar
Seminars in Respiratory and Critical Care Medicine|May 25, 2010
Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPDJill A Ohar, James F Donohue
Current Opinion in Pulmonary Medicine|January 2, 2024
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary diseaseChee Hong Loh, Jill A Ohar
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 22, 2017
Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder InhalersSohini Ghosh, Jill A Ohar, M Bradley Drummond
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 25, 2019
The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive ReviewJill A Ohar, James F Donohue, Selwyn Spangenthal
Drugs|February 10, 2012
Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?Matthew C Miles, James F Donohue, Jill A Ohar
Therapeutic Advances in Respiratory Disease|November 14, 2012
Nebulized arformoterol: what is its place in the management of COPD?Matthew C Miles, James F Donohue, Jill A Ohar
Expert Opinion on Drug Safety|January 8, 2015
Review of drug safety and efficacy of arformoterol in chronic obstructive pulmonary diseaseChee H Loh, James F Donohue, Jill A Ohar
Expert Opinion on Drug Safety|January 20, 2015
Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelinesJames F Davidson, James F Donohue, Jill A Ohar
International Journal of Chronic Obstructive Pulmonary Disease|March 16, 2026
Development and Validation of an Electronic Health Record Algorithm to Predict the Presence of Chronic Obstructive Pulmonary DiseaseBrian J Wells, Amit K Saha, Jill A Ohar
Pageof 6